benzyl isothiocyanate has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
benzyl isothiocyanate: inhibits carcinogen-induced neoplasia; structure in Negwer, 5th ed, #715; also promotes urinary bladder carcinoma
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Varadarajan, S | 1 |
| Madapusi, BT | 1 |
| Narasimhan, M | 1 |
| Pandian, CD | 1 |
| Dhanapal, S | 1 |
| Wolf, MA | 1 |
| Claudio, PP | 1 |
2 other studies available for benzyl isothiocyanate and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Anticancer Effects of
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Carica; Cell Line; Head and Neck Neoplasms; Humans; | 2022 |
Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Cisplatin; Gene | 2014 |